Skip to search formSkip to main contentSkip to account menu

zopolrestat

Known as: 3,4-Dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazineacetic Acid, 3,4-dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazine-acetic acid 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (4)

BenzothiazolesEnzyme InhibitorsHypoglycemic AgentsPhthalazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Chapterr 5 EFFECTSS OF INHIBITION OF THE POLYOL PATHWAY DURING CHRONICC PERITONEAL EXPOSURE TO A DIALYSIS SOLUTION
T I N T R O D U C T I ON N Peritoneall dialysis with glucose and lactate containing dialysis solutions stimulates peritoneal… 
2015
2015
PP.33.22: ALDOSE REDUCTASE INHIBITORS, ZOPOLRESTAT AND FERULIC ACID, ALLEVIATE METABOLIC SYNDROME EFFECT ON ENDOTHELIAL DEPENDENT RELAXATION
Objective: We have previously shown that aldose reductase (AR) inhibition, alleviate hypertension in diabetes. Here, we… 
2011
2011
Induced fit binding of aldose reductase inhibitors to AKR1B10
AKR1B10 is a recently identified NADP+ dependent aldo–keto reductase. It is strongly over expressed in lung and hepatic… 
1999
1999
Effect of high galactose concentrations and zopolrestat on intracellular sodium and potassium of lens epithelial cells
1995
1995
PHARMACOKINETICS IN NON‐INSULIN‐DEPENDENT DIABETICS OF THE ALDOSE REDUCTASE INHIBITOR, ZOPOLRESTAT
The pharmacokinetics of zopolrestat have been examined in non-insulin-dcpendent diabetic patients after oral administration of a…